Skip to main content
Premium Trial:

Request an Annual Quote

WaferGen, IDT Form Alliance for Gene Expression Assay Primers

NEW YORK (GenomeWeb News) – WaferGen Biosystems today said that it has "established a relationship" with Integrated DNA Technologies to provide IDT's PrimeTime qPCR primers for SYBR-based gene expression assays.

Financial and other terms of the deal were not announced. WaferGen announced the deal in conjunction with the launch of its MyDesign open-format, high-throughput qPCR platform.

IDT has developed more than 800,000 SYBR-based gene expression assays using a design engine that eliminates cross reactivity and that includes SNP and intron/exon junction information, WaferGen said. It and IDT will collaboratively provide custom assay design services for formalin-fixed, paraffin-embedded-derived samples to WaferGen customers, it added.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.